Actively Recruiting
Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization
Led by Centre Hospitalier Universitaire Dijon · Updated on 2024-07-22
88
Participants Needed
1
Research Sites
146 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The PRéPaR project aims to construct, with the help of parents and early care providers, a support program for the families of infants at an increased risk for neurodevelopmental disorders, and to evaluate the acceptability and feasibility of such a program. This program aims to strengthen parenting skills, support infant development and improve the continuity of hospital/non-hospital care, including early identification of neurodevelopmental motor disorders and continuation of the support initiated during neonatal hospitalization.
CONDITIONS
Official Title
Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For WP1 parents of children with neurodevelopmental difficulties, the child must be 18 to 48 months corrected age.
- Child must have at least one high neurodevelopmental risk factor at birth: preterm ≤ 31 weeks + 6 days, birth weight under 1500g, stroke or stage 2 or 3 hypoxic-ischaemic encephalopathy, or central neurological lesion.
- Child must have an abnormal, non-transient clinical state such as diagnosed or in-progress cerebral palsy, central neurological syndrome, or neurodevelopmental disorder.
- Parents must be able to participate in 3 interviews.
- For WP1 infants at high neurodevelopmental risk at hospital discharge, child must be 34 weeks amenorrhea to 12 months corrected age.
- Child must have at least one high neurodevelopmental risk factor at birth as above.
- Parents must be able to participate in 3 interviews.
- Professionals and parent support groups involved must have agreed to participate.
- For WP2, parents of children hospitalized at CHU Dijon must be between 34 weeks amenorrhea and 3 months corrected age.
- Child must have had a stroke or stage 2 or 3 hypoxic-ischaemic encephalopathy or central neurological lesion.
- Professionals involved in care must have agreed to participate.
You will not qualify if you...
- Parents physically or cognitively unable to participate in group interviews or lacking sufficient French language skills.
- Parents who are minors.
- Parents under legal protection.
- Parents of children with major orthopedic or traumatic disorders unrelated to cerebral palsy risk.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Dijon Bourgogne
Dijon, France, 21000
Actively Recruiting
Research Team
S
Sandrine JANDET CARON
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here